Sentrx announced today that Christopher Metzler, DPM, has joined the firm as Director of Quality Standards. Dr. Metzler has extensive experience in global pharmacovigilance and drug information systems compliance and auditing. He will be responsible for the regulated document system; process improvement initiatives; and responses to client, health authority and business partner audits.
Little Falls, NJ (PRWEB) November 12, 2007 -- Sentrx, the leading provider of technology-enabled drug safety services, announced today that Christopher Metzler, DPM, has joined the firm as Director of Quality Standards.
Dr. Metzler has extensive experience in global pharmacovigilance and drug information systems compliance and auditing. He spent nearly five years with Schering-Plough Corporation, holding positions of increasing responsibility in Drug Safety Surveillance Compliance, Operations and Training. As Senior Global Drug Information Services Compliance Manager, Dr. Metzler oversaw audits, standard operating procedure (SOP) development and compliance, training and medical inquiry support.
Most recently, Dr. Metzler was Audit Manager for Wyeth Pharmaceuticals' Global Business Compliance group. There he was responsible for auditing headquarters, affiliates, and business partners for pharmacovigilance, privacy, labeling and medical information practices against international laws and regulations and company policies and procedures. During his tenure, he audited more than 200 drug safety SOPs and maintained an excellent level of understanding of current global pharmacovigilance legislation and guidance.
Prior to entering the pharmaceutical industry, Dr. Metzler was a pharmacist and a practicing podiatrist. He graduated from Rutgers College of Pharmacy in 1984 and from New York College of Podiatric Medicine in 1989. He holds NJ licenses for Podiatry and for Pharmacy, and he is certified by the American Board of Podiatric Orthopedics.
"We are pleased to expand our Quality Standards group with Dr. Metzler," said Joseph Albano, Chief Executive Officer of Sentrx. "His depth of expertise in global pharmacovigilance compliance will help maintain the excellent reputation Sentrx has earned to date, even as our client base doubles and triples in numbers. His practical experience in the pharmacy and in private practice will also be important as we address the need for risk evaluation and mitigation strategies that the FDA Authorization Act has intensified."
"The entrepreneurial spirit of Sentrx attracted me to the company," said Dr. Metzler. " I look forward to applying my experience in drug safety compliance to a business environment that meets the needs of diverse clients."
At Sentrx, Dr. Metzler will be responsible for the regulated document system; process improvement initiatives; and responses to client, health authority and business partner audits. He will report directly to Dr. Doreen Lechner, Senior Vice President of Quality Standards.
About Sentrx
Sentrx is the leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products, during clinical development and post approval, enabling its clients to maximize benefits and minimize risk. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please visit its website at www.sentrx.com ; or call 1-888-399-8032, extension 261.
Contact:
Jill Notte
Executive Director, Marketing
Sentrx
Overlook at Great Notch
150 Clove Road
Little Falls, NJ 07424
Phone: 973-812-7575 ext. 261
Fax: 973-812-9094
Website: www.sentrx.com
###
Trackback URL: http://www.prweb.com/pingpr.php/TWFnbi1Qcm9mLUxvdmUtWmV0YS1UaGlyLVplcm8=
|
